The SMC brought together a panel of scientists to answer journalists’ questions about what we do and don’t know from the evidence so far about the B.1.617.2 delta variant, and what uncertainties remain.
Speakers included:
Dr Jeff Barrett, Director of the COVID-19 Genomics Initiative, the Wellcome Sanger Institute
Prof Wendy Barclay, G2P-UK lead, and Action Medical Research Chair in Virology, Imperial College London
Prof Neil Ferguson, Director of the MRC Centre for Global Infectious Disease Analysis, Imperial College London